Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-26-003809
Filing Date
2026-01-27
Accepted
2026-01-27 16:30:27
Documents
1
Period of Report
2026-01-26

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3247
  Complete submission text file 0001493152-26-003809.txt   4983
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ENTRADA THERAPEUTICS, INC. 6 TIDE STREET BOSTON MA 02210
Business Address
Zeiher Bernhardt G (Reporting) CIK: 0001971421 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 26566001